Bayer Logo Bayer Logo Bayer Logo Bayer Logo

PAH PATIENT PROFILES

Which patients may consider Adempas?

Patricia
Meet Patricia
 

PAH (WHO GROUP 1) WITH ERA

53 years old  WHO FC III  6MWD of 368 m  PVR 834 dyn-s-cm-5  NT-proBNP 732 ng/l
Patricia was diagnosed with PAH 2 years ago and is currently on PAH therapies. During her recent visit to her PH specialist, she complained of gradually worsening shortness of breath while doing her normal routine.
PATRICIA’S GOAL: To dance again to her favorite song

Use a goal-oriented approach when assessing patients like Patricia

At Patricia’s last visit, she complained of gradually increasing shortness of breath in her daily routine, followed by chest pain and fatigue. Her symptoms have gradually worsened.
Today’s visit: Tests confirmed that her PAH has not yet improved, therefore you decide to initiate Adempas. You discuss with her how to initiate Adempas therapy in the context of her current medical treatment. Learn more here.
YOUR GOAL: Improve Patricia’s 6MWD and WHO functional class
6MWD=6-minute walk distance; ERA=endothelin receptor antagonist; FC=functional class; NT-proBNP=N-terminal pro-brain natriuretic peptide; PAH=pulmonary arterial hypertension; PH=pulmonary hypertension; PVR=pulmonary vascular resistance; WHO=World Health Organization
CTA patient profile promo
HELP PATRICIA DANCE TO HER FAVORITE SONG AGAIN
 
Meet Patricia
PAH (WHO GROUP 1) WITH ERA

53 years old

WHO FC III

6MWD of 368 m

PVR 834 dyn-s-cm-5

NT-proBNP 732 ng/l

Patricia
Patricia was diagnosed with PAH 2 years ago and is currently on PAH therapies. During her recent visit to her PH specialist, she complained of gradually worsening shortness of breath while doing her normal routine.
PATRICIA’S GOAL: To dance again to her favorite song

Use a goal-oriented approach when assessing patients like Patricia

At Patricia’s last visit, she complained of gradually increasing shortness of breath in her daily routine, followed by chest pain and fatigue. Her symptoms have gradually worsened.

Today’s visit: Tests confirmed that her PAH has not yet improved, therefore you decide to initiate Adempas. You discuss with her how to initiate Adempas therapy in the context of her current medical treatment. Learn more here.

YOUR GOAL: Improve Cassie’s PVR and WHO functional class

6MWD=6-minute walk distance; ERA=endothelin receptor antagonist; FC=functional class; NT-proBNP=N-terminal pro-brain natriuretic peptide; PAH=pulmonary arterial hypertension; PH=pulmonary hypertension; PVR=pulmonary vascular resistance; WHO=World Health Organization

CTA patient profile promo

HELP PATRICIA DANCE TO HER FAVORITE SONG AGAIN

 
MORE IMPORTANT SAFETY INFORMATION LESS IMPORTANT SAFETY INFORMATION